Tesamorelin
Tesamorelin Acetate
An FDA-approved GHRH analog primarily used for reducing visceral fat. One of the few peptides with robust clinical trial data in humans for body composition improvement.
Key Research
Peer-Reviewed Evidence • 3 Citations
Tesamorelin reduces visceral fat and improves body composition in HIV-infected patients
Falutz J et al.•N Engl J Med•2007•PMID: 17942874
Key Finding: Tesamorelin achieved 15.2% reduction in visceral adipose tissue vs placebo, with improvements in triglycerides and body image.
View on PubMedTesamorelin, a GHRH analog, reduces liver fat and fibrosis in HIV-associated NAFLD
Stanley TL et al.•J Clin Invest•2021•PMID: 33855975
Key Finding: Tesamorelin significantly reduced hepatic fat fraction and prevented liver fibrosis progression in a randomized controlled trial.
View on PubMedEffects of tesamorelin on body composition, visceral fat and metabolic parameters
Dhillon S•Drugs•2011•PMID: 21548606
Key Finding: FDA-approved tesamorelin demonstrated consistent visceral fat reduction across multiple phase III trials with minimal adverse effects.
View on PubMedCitations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.
📊 Evidence by Outcome
FDA-approved for HIV-associated lipodystrophy. Strong human data showing significant visceral fat reduction.
12 studies • Consistency: High • Effect: Large
Reduces trunk fat while preserving lean mass. Effects are dose-dependent.
8 studies • Consistency: High • Effect: Moderate
👥 Community Insights
Visceral fat noticeably reduced after 8 weeks — DEXA scan confirmed.
Community member • Dubai• Verified
📋 Protocol Snapshot
Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.
Related Treatments
Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, community data, and other factors — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.